The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Official Title: TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study - TIGER Meso Study
Study ID: NCT05538806
Brief Summary: The purpose of this post-authorisation medical device study is to obtain real life data on the use of Tumor Treating Fields (TTFields) in patients with pleural mesothelioma in routine clinical care. Patients with pleural mesothelioma and clinical indication for TTFields treatment will be enrolled in the study after signing Informed consent to use their data and process it centrally for research purposes. The clinical indication for TTFields is one of the inclusion criteria and is defined prior to inclusion by the treating physician.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Lungenklinik Gauting, Gauting, Bavaria, Germany
University Hospital Regensburg, Regensburg, Bavaria, Germany
Asklepios Klinikum Harburg, Hamburg-Harburg, Hamburg, Germany
University Hospital Carl Gustav Carus Dresden, Dresden, Saxony, Germany
Lungenklinik Heckeshorn, Berlin, , Germany
Klinikum Bremen-Ost, Bremen, , Germany
Kliniken der Stadt Koeln, Cologne, , Germany
Klinikum Essen-Mitte, Essen, , Germany
University Hospital Essen, Essen, , Germany
Krankenhaus Martha-Maria Halle-Doelau, Halle, , Germany
Lungenklinik Hemer, Hemer, , Germany
Krankenhaus Bethanien Moers, Moers, , Germany
Fachkliniken Wangen, Wangen, , Germany
Azienda Ospedaliero-Universitaria di Alessandria "SS. Antonio e Biagio e C. Arrigo", Alessandria, , Italy
Humanitas Gavazzeni, Bergamo, , Italy
Erasmus MC Cancer Centre, Rotterdam, , Netherlands